3.1 million dollars has been awarded by the NIH to the University of Rochester School of Medicine and Dentistry for “innovative, high risk, high impact “ HIV vaccine investigation.  It should be intriguing to hear about the work and results from this bold approach.The lessons learned could be far reaching certainly for HIV prevention specifically but also for future vaccine development in general. http://vaccinenewsdaily.com/stories/510639966-university-of-rochester-receives-funding-for-hiv-vaccine-development